期刊文献+

EGFR基因突变与非小细胞肺癌相关研究进展

下载PDF
导出
摘要 目前,肺癌依然是导致人类肿瘤性致死的首位疾病,全球每年因肺癌死亡的人数超过100万,其中80%~90%的患者为非小细胞肺癌(non-small-celllungcancer,NSCLC)。
出处 《华北理工大学学报(医学版)》 2016年第5期413-420,共8页 Journal of North China University of Science and Technology:Health Sciences Edition
基金 2016年河北省政府资助临床医学优秀人才培养和基础课题研究项目(编号:361036)
  • 相关文献

参考文献6

二级参考文献70

  • 1张晓彤,李龙芸,王树兰,穆新林,王孟昭.吉非替尼治疗晚期非小细胞肺癌疗效观察[J].中华结核和呼吸杂志,2005,28(3):180-183. 被引量:31
  • 2BaoMingQIN,XiaoCHEN,JingDeZHU,DuanQingPEI.Identification of EGFR kinase domain mutations among lung cancer patients in China:implication for targeted cancer therapy[J].Cell Research,2005,15(3):212-217. 被引量:66
  • 3Maria Sibilia, Renate Kroismayr, Beate M, et al. The epidermal growth factor receptor: from development to Tumorigenesis. Differentiation, 2007, 75(9): 770-787.
  • 4Lynch TJ, Bell DW, SordeUa R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness ofnon-small-cen lung cancer to gefitinib. N EnglJ Med, 2004, 350(21): 2129-2139.
  • 5Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science, 2004, 304(5676): 1497-1500.
  • 6Kosaka T, Yatabe Y, Endoh H, et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implecations. Cancer Res, 2004, 64(24): 8919-8923.
  • 7Cappuzzo F, Hirsch FR, Rossi E, et al. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small cell lung cancer.J Natl Cancer Inst, 2005, 97(9): 643-655.
  • 8Han SW, Kim TY, Jeon YK, et al. Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation. Clio Cancer Res, 2006, 12(8): 2538-2544.
  • 9Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J. Cancer, 2006, 118(2): 257-262.
  • 10Mitsudomi T, Kosaka T, Endoh H, et al. Mutations oft_he epidermal growth factor receptor gene pridict prolonged survival after gefitinib treatment in patients with non-mall-cell lung cancer with postoperative recurrence. J Clin Oncol, 2005, 23 ( 11 ): 2513-2520.

共引文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部